bioRxivCancer BiologyPreprint
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States
Ryan A. DenuiD, Zhao Zheng, Yingda JiangiD, Suresh SatpatiiD, Veena KochatiD, Kumaren Anand, Danh D. TruongiD, Andrew R. LynchiD, William I. Padron, Davis R IngramiD, Khalida WaniiD, Diana ShamsutdinovaiD, Angela D. BhallaiD, Sharon M. LandersiD, Ravin RataniD, Neeta SomaiahiD, Christina Lynn RolandiD, Keila E. TorresiD, Peter Van LooiD, Pamela T. SolimaniD, Larissa Alejandra MeyeriD, Alexander J. LazariD, Emily Zhi-Yun KeungiD, Elise F Nassif Haddad, Kunal RaiiD
Abstract
Leiomyosarcoma is a smooth muscle-derived malignancy marked by significant clinical heterogeneity. The extent and nature of cellular heterogeneity and molecular underpinnings remain poorly understood. To address this at transcriptomic and epigenomic levels, we performed single-nucleus multiome sequencing on untreated primary leiomyosarcoma tissues. Malignant cells segregated almost exclusively into two previously unrecognized and epigenetically distinct states: a dedifferentiated, mesenchymal-like subtype (MES) and a differentiated smooth muscle-enriched subtype (SMC). Chromatin accessibility profiling revealed strong enrichment of nuclear factor I (NFI) transcription factor motifs in MES cells, whereas AP-1 family motifs--most prominently FOSL2--were selectively accessible in SMC cells. Established leiomyosarcoma cell lines faithfully recapitulated these subtypes, and targeted depletion of NFI or AP-1 factors suppressed proliferation, invasion, and in vivo tumor growth, demonstrating functional dependency on these transcriptional programs. Spatial transcriptomics across 328 tissue cores from 128 leiomyosarcomas showed that immunosuppressive macrophages preferentially cluster around MES regions, revealing a subtype-specific tumor-immune niche. Clinically, MES-dominant tumors were associated with significantly worse patient outcomes. Through an epigenetic inhibitor screen, we identify and validate SMARCA4/2 inhibition as a promising therapeutic vulnerability for MES leiomyosarcomas. Together, this work defines two epigenetically driven, transcription factor-regulated, and clinically relevant states of leiomyosarcoma, revealing mechanistic underpinnings of tumor heterogeneity and uncovering actionable therapeutic strategies. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=93 HEIGHT=200 SRC="FIGDIR/small/726988v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@132928eorg.highwire.dtl.DTLVardef@133e3b7org.highwire.dtl.DTLVardef@1ab4398org.highwire.dtl.DTLVardef@e2de25_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: scRNA-seq
- assay: ATAC-seq
- assay: spatial transcriptomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: deep learning
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Distinct cellular origins and differentiation process account for distinct oncogenic and clinical behaviors of leiomyosarcomas
- Machine Learning Analysis to Define Cell Lineage in Leiomyosarcoma
David G.P. van IJzendoorn, Joanna Przybył, … Matt van de Rijn·bioRxiv·May 12, 2026
- Heterogeneity in the gene regulatory landscape of leiomyosarcoma.
Tatiana Belova, Nicola Biondi, … Marieke L. Kuijjer·NAR CancerPeer-reviewed·Jun 9, 2023
- Spatially-resolved single cell atlas of liposarcoma reveals lineage hierarchies, immune niches, and regulatory circuits
Ryan A. Denu, Veena Kochat, … Kunal Rai·bioRxiv·Mar 25, 2026
- Matched primary-metastasis single-nucleus and spatial profiling of leiomyosarcoma identifies antigen-presenting fibroblasts at the tumor-organ interface
Anna Kübler, Linda Bergmayr, … Andreas Möck·bioRxiv·Oct 5, 2026
- Multidimensional Single-Cell Transcriptomic Profiling of Uterine Leiomyosarcomas Reveals Distinct Tumor States with Inferred Therapeutic Vulnerabilities
Maria Moozhiyil Korah, James Paul Agolia, … Daniel Delitto·bioRxiv·Nov 17, 2025